Serina Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Serina Therapeutics has a total shareholder equity of $4.1M and total debt of $3.0M, which brings its debt-to-equity ratio to 72.6%. Its total assets and total liabilities are $9.0M and $4.9M respectively.
Key information
72.6%
Debt to equity ratio
US$2.98m
Debt
Interest coverage ratio | n/a |
Cash | US$7.62m |
Equity | US$4.11m |
Total liabilities | US$4.86m |
Total assets | US$8.97m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SER's short term assets ($7.6M) exceed its short term liabilities ($1.4M).
Long Term Liabilities: SER's short term assets ($7.6M) exceed its long term liabilities ($3.4M).
Debt to Equity History and Analysis
Debt Level: SER has more cash than its total debt.
Reducing Debt: Insufficient data to determine if SER's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: SER's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if SER's interest payments on its debt are well covered by EBIT.